Stereotaxis, Inc. (STXS) Stock Forecast

NYSE American: STXSAnalyst ratings, price target and estimates.

STXS analyst forecast

as of October 18, 2026
Analyst consensus
Strong buy
4.50 / 5 from 4 analysts
Price target
$3.00
average of analyst targets
Upside to target
+197.0%
from the latest close
Next earnings
November 10, 2026
52-week range
$1.01 – $3.10

STXS analyst ratings

4 analysts
Strong buy
250%
Buy
250%
Hold
00%
Sell
00%
Strong sell
00%

Number of analysts at each rating.

STXS price target

Price $1.01Target $3.00
52-week low $1.0152-week high $3.10

The average of analyst 12-month price targets compared with the latest close and the 52-week range.

STXS earnings per share estimates

Stereotaxis, Inc. EPS estimates
PeriodAverageLowHighYear agoGrowthAnalysts
Current quarter (Sep '26)−$0.06−$0.06−$0.05−$0.07+21.4%2
Current fiscal year (2026)−$0.21−$0.22−$0.20−$0.25+16.0%2
Next fiscal year (2027)−$0.15−$0.17−$0.14−$0.21+26.2%2

Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.

STXS revenue estimates

Stereotaxis, Inc. revenue estimates
PeriodAverageLowHighGrowthAnalysts
Current quarter (Sep '26)$9.6M$9.3M$10.0M+28.6%3
Current fiscal year (2026)$34.3M$33.5M$35.0M+6.0%3
Next fiscal year (2027)$45.7M$43.5M$47.0M+33.0%3

STXS EPS: reported and forecast

Reported EPSEstimate (average; low–high)

Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.

STXS revenue: reported and forecast

Reported revenueEstimate (average; low–high)

STXS EPS estimate revisions

Stereotaxis, Inc. EPS estimate revisions
Period90 days ago60 days ago30 days ago7 days agoNowChange (90 d)Revisions (30 d)
Current quarter (Sep '26)−$0.05−$0.05−$0.05−$0.05−$0.06+17.8%0 up · 1 down
Current fiscal year (2026)−$0.19−$0.19−$0.19−$0.19−$0.21+10.5%1 up · 1 down
Next fiscal year (2027)−$0.13−$0.13−$0.13−$0.13−$0.15+22.3%1 up · 1 down

How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.

STXS earnings surprises

Reported EPSEstimate

Reported EPS vs the consensus estimate for the last 12 quarters; STXS beat in 5 of 12.

What analysts expect from STXS

4 analysts cover Stereotaxis; their consensus rating is strong buy (4.50 on a 1–5 scale, where 5 is a strong buy). The average price target is $3.00, 197.0% above the latest close of $1.01. Analysts expect earnings of −$0.21 per share for 2026, +16.0% from a year earlier. For 2027 the average estimate is −$0.15 per share on revenue of $45.7 million. Stereotaxis beat the EPS estimate in 5 of the last 12 quarters.

Related: STXS income statement, STXS key metrics, STXS chart. See the STXS stock overview for the latest quote and news.

STXS forecast FAQ

What is Stereotaxis's price target?

The average analyst price target for Stereotaxis is $3.00, 197.0% above the latest close of $1.01.

Is Stereotaxis a buy, hold or sell?

Of 4 analysts covering Stereotaxis, 2 rate it a strong buy, 2 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.

What is Stereotaxis's EPS forecast?

Analysts forecast −$0.21 per share for 2026 (range −$0.22 to −$0.20); for 2027 the estimate is −$0.15.

What is Stereotaxis's revenue forecast?

The average revenue estimate for 2026 is $34.3 million, growth of 6.0%; for 2027 it is $45.7 million.

When does Stereotaxis report earnings?

Stereotaxis is expected to report results for the quarter ending September 30, 2026 on November 10, 2026.

Does Stereotaxis usually beat earnings estimates?

Stereotaxis reported EPS at or above the analyst estimate in 5 of the last 12 quarters.

Medical Instruments & Supplies: forecast